Last reviewed · How we verify
C326, IL-6 Inhibitory Avimer protein — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
C326, IL-6 Inhibitory Avimer protein (C326, IL-6 Inhibitory Avimer protein) — Avidia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| C326, IL-6 Inhibitory Avimer protein TARGET | C326, IL-6 Inhibitory Avimer protein | Avidia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- C326, IL-6 Inhibitory Avimer protein CI watch — RSS
- C326, IL-6 Inhibitory Avimer protein CI watch — Atom
- C326, IL-6 Inhibitory Avimer protein CI watch — JSON
- C326, IL-6 Inhibitory Avimer protein alone — RSS
Cite this brief
Drug Landscape (2026). C326, IL-6 Inhibitory Avimer protein — Competitive Intelligence Brief. https://druglandscape.com/ci/c326-il-6-inhibitory-avimer-protein. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab